BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3491138)

  • 21. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris.
    Menssen A; Trommler P; Vollmer S; Schendel D; Albert E; Gürtler L; Riethmüller G; Prinz JC
    J Immunol; 1995 Oct; 155(8):4078-83. PubMed ID: 7561119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid lymphocyte chemoattractants in psoriasis.
    Bacon KB; Camp RD
    Prostaglandins; 1990 Dec; 40(6):603-14. PubMed ID: 2093937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse transcriptase activity in human normal and psoriatic skin samples.
    Molès JP; Tesniere A; Guilhou JJ
    Br J Dermatol; 2007 Sep; 157(3):482-6. PubMed ID: 17614977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of lymphocyte migration by a novel low-molecular weight compound in normal human skin and plasma.
    Bacon KB; Fincham NJ; Camp RD
    Eur J Immunol; 1990 Mar; 20(3):565-71. PubMed ID: 2180725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotrienes C4 and D4 in psoriatic skin lesions.
    Brain SD; Camp RD; Black AK; Dowd PM; Greaves MW; Ford-Hutchinson AW; Charleson S
    Prostaglandins; 1985 Apr; 29(4):611-9. PubMed ID: 2988023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1: a key inflammatory mediator in psoriasis?
    Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
    Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of correlation between interleukin 6 and interleukin 1 levels in psoriatic lesional skin.
    Takematsu H; Tagami H
    Tohoku J Exp Med; 1994 Mar; 172(3):243-52. PubMed ID: 8073436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
    Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
    J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there any correlation between the total number of neutrophils in plasma and concentration of interleukin-8 in psoriatic patients?
    Pietrzak A; Kozioł-Montewka M; Lecewicz-Toruń B; Krasowska D
    Med Sci Monit; 2000; 6(5):867-70. PubMed ID: 11208423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
    Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
    Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil-activating proteins in psoriasis.
    Schröder JM; Gregory H; Young J; Christophers E
    J Invest Dermatol; 1992 Feb; 98(2):241-7. PubMed ID: 1732389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of, lipid neutrophil chemoattractant activity by histamine-stimulated cultured endothelial cells.
    Farber HW; Weller PF; Rounds S; Beer DJ; Center DM
    J Immunol; 1986 Nov; 137(9):2918-24. PubMed ID: 3760577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
    Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
    Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.
    Companjen A; van der Wel L; van der Fits L; Laman J; Prens E
    Eur Cytokine Netw; 2004; 15(3):210-6. PubMed ID: 15542445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased levels of IL-1 alpha and beta in psoriatic lesional skin.
    Takematsu H; Ohmoto Y; Tagami H
    Tohoku J Exp Med; 1990 Jul; 161(3):159-69. PubMed ID: 2247888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of IL-1 inhibitor in psoriatic scale extracts.
    Terui T; Suzuki R; Kumagai K; Takematsu H; Kato T; Tagami H
    Tohoku J Exp Med; 1988 Oct; 156(2):149-56. PubMed ID: 3266382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemotaxis of polymorphonucleated leukocytes in the presence of skin extracts and psoriatic scales].
    Offidani A; Valentino M; Fortunati R; Fidecicchi G; Bossi G
    G Ital Dermatol Venereol; 1988 Mar; 123(3):71-4. PubMed ID: 3410501
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.
    Schröder JM; Christophers E
    J Invest Dermatol; 1986 Jul; 87(1):53-8. PubMed ID: 3014008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte chemoattractants in psoriasis and normal skin.
    Camp RD; Bacon KB; Fincham NJ
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):22S-23S. PubMed ID: 16788623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.